Serum 25‑Hydroxyvitamin D and other risk factors for patent ductus arteriosus in preterm neonates: A retrospective study
Background & Objective: Patent ductus arteriosus (PDA) is prevalent among preterm infants and can affect heart and lung function, lower systemic blood pressure, and lead to various complications. In this study, we aimed to analyse early postnatal serum 25-hydroxyVitamin-D [25(OH)D] levels in preterm infants and to explore risk factors for PDA. Methodology: This retrospective study included clinical data from premature infants admitted to the neonatology department of our hospital between December 2021 to November 2023. The population was grouped by demographic and clinical characteristics and 25(OH)D levels were compared within each group. Logistic regression analysis was employed to identify the risk factors for PDA. Results: A total of 429 preterm infants were enrolled. Vitamin-D deficiency or insufficiency was prevalent among preterm infants. Preterm infants born in winter, by caesarean section, those undergoing tracheal intubation, and those with neonatal respiratory distress syndrome (NRDS) and PDA had significantly lower Vitamin-D levels. Multivariate logistic regression analysis identified caesarean delivery and NRDS as risk factors for PDA. However, higher Vitamin-D levels and greater gestational age were protective factors against PDA. Conclusion: Preterm infants frequently experience Vitamin-D deficiency or insufficiency. 25(OH)D levels, delivery methods, gestational age, and NRDS affect the occurrence of PDA.
Authors
- Mingjie Geng
- Chun Shen
- Haiping Yang
- Shiguang Zhang
Institutions
- Cangzhou Central Hospital (CN)
Publication Details
- Journal
- Pakistan Journal of Medical Sciences
- Published
- 2026-11-19
- DOI
- https://doi.org/10.12669/pjms.42.12.20285
- Primary Topic
- Cardiovascular Conditions and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00